| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/03/2005 | US20050026822 Human 3 relaxin |
| 02/03/2005 | US20050025810 Treatment of ocular disease |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/03/2005 | DE10332472A1 Ambroxol für die Behandlung von Tinnitus Ambroxol for the treatment of tinnitus |
| 02/03/2005 | CA2770493A1 Cyclohexanecarboxylic acid compound |
| 02/03/2005 | CA2533594A1 Compounds for inflammation and immune-related uses |
| 02/03/2005 | CA2533101A1 Dispersible formulation of an anti-inflammatory agent |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/03/2005 | CA2528586A1 Cyclohexanecarboxylic acid compound |
| 02/02/2005 | EP1502949A1 Antimicrobial polypeptide and utizliation thereof |
| 02/02/2005 | EP1502916A1 Piperidine derivatives having ccr3 antagonism |
| 02/02/2005 | EP1502600A1 Use of botulinum toxin for treating smooth muscle disorders |
| 02/02/2005 | EP1502595A1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof |
| 02/02/2005 | EP1502590A1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes |
| 02/02/2005 | EP1501948A1 A dna enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/02/2005 | EP1501936A2 Cytokine protein family |
| 02/02/2005 | EP1501834A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501833A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501830A1 7-aryl-3,9-diazabicyclo[3.3.1]non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501826A2 Substituted indoles as alpha-1 agonists |
| 02/02/2005 | EP1501817A1 Imidazolinylmethyl aralkylsulfonamides |
| 02/02/2005 | EP1501808A1 Tachykinin receptor antagonists |
| 02/02/2005 | EP1501807A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 02/02/2005 | EP1501801A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/02/2005 | EP1501797A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 02/02/2005 | EP1501796A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 02/02/2005 | EP1501545A2 Use of tnfalpha antibodies and another drug |
| 02/02/2005 | EP1501530A2 Prostaglandin f2 alpha analogs in combination with antimicrobial for treating glaucoma |
| 02/02/2005 | EP1501518A2 Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders |
| 02/02/2005 | EP1501515A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501511A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway |
| 02/02/2005 | EP1501508A1 Inhibitors of histone deacetylase |
| 02/02/2005 | EP1501505A1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h- 1,2,4 -t riazole for the treatment of autoimmune diseases |
| 02/02/2005 | EP1501482A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 02/02/2005 | EP1362050B1 Pyrimidine derivatives for inhibition of cell-proliferation |
| 02/02/2005 | EP1351980A4 Peptides for activation and inhibition of delta pkc |
| 02/02/2005 | EP1303521B1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 02/02/2005 | EP1242395B1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 02/02/2005 | EP1161235B1 Combinations for the treatment of diseases involving angiogenesis |
| 02/02/2005 | EP1124779B1 Vitamin d analogues |
| 02/02/2005 | EP1025079B1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 02/02/2005 | EP1023077B1 Opthalmic composition |
| 02/02/2005 | CN1575289A 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same |
| 02/02/2005 | CN1575182A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/02/2005 | CN1575181A Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 02/02/2005 | CN1575178A Method and composition for treatment of ocular hypertension and glaucoma |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1575176A Process for making substituted pyrazoles |
| 02/02/2005 | CN1575172A Substituted ideno[1, 2-c]isoquinoline derivatives and methods of use thereof |
| 02/02/2005 | CN1575163A Granule formulation |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1187370C Connective tissue growth factor fragments and methods and uses thereof |
| 02/02/2005 | CN1187358C Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 02/02/2005 | CN1187337C Thiobenzimidazole derivatives |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/02/2005 | CN1187089C Application of photosensitizer in preparing medicine for lightening and preventing inflammation of damnified tissue |
| 02/02/2005 | CN1187060C Extracts of shark cartilage, its preparation method and usage |
| 02/01/2005 | US6849658 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/01/2005 | US6849655 Aqueous liquid formulations |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis |
| 02/01/2005 | US6849635 Sulfonamides |
| 02/01/2005 | US6849630 Cyclized amino acid derivatives |
| 02/01/2005 | US6849625 Use in manufacture of a medicament for use as an anti-invasive agent in containment and/or treatment of solid tumor disease |
| 02/01/2005 | US6849624 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders |
| 02/01/2005 | US6849612 Oligonucleotide modulation of cell adhesion |
| 02/01/2005 | CA2296080C Ophthalmic compositions containing galactomannan polymers and borate |
| 01/27/2005 | WO2005007838A1 Cell diffrentiation inhibitor, cell culture method using the same, liquid culture medium and cultured cell line |
| 01/27/2005 | WO2005007161A1 Remedy for pruritus comprising piperidine derivative as the active ingredient |
| 01/27/2005 | WO2005007147A1 Ambroxol for treating tinnitus |
| 01/27/2005 | WO2004043447A3 Compositions and methods for treating or preventing hearing impairment |
| 01/27/2005 | US20050020837 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 01/27/2005 | US20050020813 Streptococcus pneumoniae proteins and nucleic acids |
| 01/27/2005 | US20050020661 Antidiabetic agents |
| 01/27/2005 | US20050020609 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 01/27/2005 | US20050020562 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020481 Ion channel modulating compounds and uses thereof |
| 01/27/2005 | US20050019908 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019826 Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof |
| 01/27/2005 | US20050019754 Peptides of given sequence with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |
| 01/27/2005 | US20050019417 stabilization of proteins, peptides or cells by fluidization of microparticles to form fluidized bed of microparticles comprising water soluble gel forming solid particles, then spraying coating with liquids comprising sugars and solvents, and drying |
| 01/27/2005 | US20050019378 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 01/27/2005 | DE10328260A1 Flupirtine-Präparat Flupirtine preparation |
| 01/27/2005 | CA2532304A1 Ambroxol for treating tinnitus |
| 01/27/2005 | CA2528372A1 Inhibition of apoptosis-specific elf-5a ("eif-5a1") with antisense oligonucleotides and sirnas as anti-inflammatory therapeutics |
| 01/26/2005 | EP1500658A1 Novel thiol derivative, process for producing the same and use thereof |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1499735A2 Optimization of transgene expression in mammalian cells |
| 01/26/2005 | EP1499631A2 Rna interference mediated inhibition of tgf-beta and tgf-beta receptor gene expression using short interfering nucleic acid (sina) |
| 01/26/2005 | EP1499613A1 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 01/26/2005 | EP1499610A2 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 01/26/2005 | EP1499606A1 3, 4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499360A2 Formulation comprising buprenorphine |
| 01/26/2005 | EP1499358A1 Ph-sensitive polymer |